Postmenopausal Virilization Due to a Rare Left Ovarian Androgen-Secreting Leydig Cell Tumor Identified by Ovarian Vein Sampling

    November 2022 in “ Journal of the Endocrine Society ”
    Shirley Shuster, Sara M. Awad
    Image of study
    TLDR A woman's masculine symptoms were caused by a rare tumor in her left ovary, which was found using a special blood test.
    A 57-year-old postmenopausal woman presented with a 10-year history of hirsutism and a 4-year history of virilization, including voice deepening, excessive hair growth, male pattern baldness, and clitoromegaly. Her total testosterone levels were significantly elevated at 11.5nmol/L, while other hormonal tests were normal. Imaging studies failed to identify any adrenal or ovarian masses. However, ovarian vein sampling indicated a strong lateralization to the left ovary, with a total testosterone level of 780nmol/L. Subsequent bilateral salpingo-oophorectomy revealed a rare left ovarian Leydig cell tumor, which was the source of the androgen secretion. Post-operatively, the patient's testosterone levels normalized, and her virilizing symptoms improved. This case underscores the importance of considering rare androgen-secreting ovarian tumors in postmenopausal virilization and the utility of ovarian vein sampling for tumor localization when imaging is inconclusive.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 24 results

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 2 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  13 upvotes 9 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

      community Any balding females? I need advice with coping :(

       16 upvotes 8 years ago
      A 27-year-old woman is struggling with hair loss, feeling self-conscious and seeking advice on coping. She mentions trying Minoxidil but is hesitant due to scalp issues and is looking for ways to regain confidence.

    Related Research

    4 / 4 results